In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1719 News Items found
Article
An illustration of a beta-amyloid plaque among the neurons in a brain.
MSK Study Links Inflammation to Alzheimer’s Disease Development

An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.
September is Pediatric Cancer Awareness Month
Pediatric Cancer Awareness Month: Making Big Strides at MSK Kids

September is Pediatric Cancer Awareness Month and at MSK, we continue to work to advance research to bring about better treatments and awareness to our youngest and most vulnerable patients not only in September, but every day.
Andrea Cercek, MD, co-director of the Center for Young Onset Colorectal Cancer at MSK
Colon Cancer in Younger Adults: MSK Colon Cancer Specialists Share Insights after Chadwick Boseman’s Passing

An uptick in colorectal cancer in people under the age of 50 is an alarming trend that led Memorial Sloan Kettering to develop the first of its kind Center for Young Onset Colorectal Cancer in 2018. Read more.
In the Lab
Black blobs on a white background
Separation Anxiety: Cell Division Gone Awry Leads to Genetic Chaos

Researchers shed light on how aberrant cell division can cause the kind of mutations often found in cancer cells.
Alexander Drilon, MD
Precision Medicine Advances: Pivotal Studies Led by MSK Published in the New England Journal of Medicine

Following an approval from the FDA in May 2020, the New England Journal of Medicine has published data from the phase I/II LIBRETTO-001 clinical trial of selpercatinib in advanced RET (REarranged during Transfection)-driven lung and thyroid cancers. MSK’s Alexander Drilon, MD, the recently appointed Chief of the Early Drug Development Service, serves as the lead investigator for multi-site clinical trial.
Intern Kathleen Navas
Commitment to Education and Mentoring: How Memorial Sloan Kettering Continued Summer Internships During the Pandemic

While numerous summer student internships were cancelled this year due to the pandemic, MSK quickly modified many of our summer student programs to enroll more than 300 interns from around the world – both virtually and in-person.
Lisa M. DeAngelis, MD, Physician-in-Chief and Chief Medical Officer of MSK
MSK Physician-In-Chief: The Time is Now for Routine Cancer Screenings

Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.
Finding
Surgeon William Jarnagin
Experimental Blood Test Uses EVP Proteins to Detect Cancer

Researchers report a new method that may enable detection of a number of different types of cancer in the early stages.
Q&A
Jeffrey Drebin, Chair of the Department of Surgery at MSK
Creating a Safe Space for Cancer Surgery at MSK: 5 Things to Know

MSK's Chair of the Department of Surgery discusses what people need to know about rescheduling treatment and what we're doing to keep you safe.
Craig B. Thompson, MD, President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center
MSK’s Craig B. Thompson, MD, Joins New York Jobs CEO Council

MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.